INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 70 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $258,000 | -23.4% | 1,931 | -7.3% | 0.01% | -12.5% |
| Q2 2021 | $337,000 | +137.3% | 2,082 | +18.0% | 0.02% | +128.6% |
| Q1 2021 | $142,000 | +105.8% | 1,764 | -49.8% | 0.01% | +75.0% |
| Q3 2020 | $69,000 | -13.8% | 3,517 | -8.9% | 0.00% | -20.0% |
| Q2 2020 | $80,000 | +7900.0% | 3,860 | +3507.5% | 0.01% | – |
| Q1 2020 | $1,000 | -50.0% | 107 | -10.1% | 0.00% | – |
| Q2 2019 | $2,000 | – | 119 | +981.8% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 11 | -85.7% | 0.00% | – |
| Q1 2018 | $2,000 | -66.7% | 77 | -73.9% | 0.00% | -100.0% |
| Q4 2017 | $6,000 | +50.0% | 295 | +74.6% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 169 | -46.9% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 318 | -17.8% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 387 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | – | 387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |